Successful long-term treatment of portal-systemic encephalopathy by the benzodiazepine antagonist flumazenil

Gastroenterology
P FerenciA Gangl

Abstract

A patient with portal-systemic encephalopathy refractory to standard therapy (40-g protein diet, oral neomycin and lactulose, supplementation of diet with branched chain amino acids) following extensive liver resection and construction of a portacaval shunt was treated with 25 mg of flumazenil twice daily by mouth. Before treatment with flumazenil she was encephalopathic and experienced 12 attacks of coma within 2 yr. When treated with flumazenil all signs of encephalopathy abated in spite of an unrestricted dietary intake of protein. Two days after discontinuation of flumazenil treatment she became comatose again. She remained chronically encephalopathic and had four further episodes of coma during the subsequent 3 mo. Since reinstitution of flumazenil treatment she has been well for 14 mo during follow-up without any signs of encephalopathy while on an unrestricted protein diet. Furthermore, flumazenil therapy reversed abnormalities of recordings of multimodality evoked potentials that were associated with hepatic encephalopathy. The striking remission of encephalopathy by treatment with flumazenil suggests that this benzodiazepine antagonist may be valuable in the long-term management of portal-systemic encephalopathy.

Citations

Sep 1, 1992·European Journal of Clinical Investigation·P FerenciP Steindl
Jan 1, 1991·Intensive Care Medicine·K Gyr, R Meier
Oct 1, 1990·DICP : the Annals of Pharmacotherapy·K A Karavokiros, G B Tsipis
Feb 1, 1990·Neurochemical Research·M Baraldi
Jul 1, 1993·Journal of Gastroenterology and Hepatology·D B Jones
Jan 31, 2002·World Journal of Gastroenterology : WJG·S vom DahlD Häussinger
Nov 7, 2001·Current Treatment Options in Gastroenterology·Srinivasan Dasarathy, Kevin D. Mullen
Mar 6, 2002·Alimentary Pharmacology & Therapeutics·C GoulenokT Poynard
Dec 11, 2002·Journal of Gastroenterology and Hepatology·Gerald Kircheis, Dieter Häussinger
Dec 17, 2009·Digestive Diseases and Sciences·Masaki SanakaYasushi Kuyama
Mar 19, 2016·Drug Metabolism Reviews·Mohd Yaseen MalikJawahar Lal
Aug 15, 1991·The New England Journal of Medicine·A S BasileP Skolnick
Mar 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·A M MansN C Rokosz
Dec 1, 1991·Metabolic Brain Disease·M G DaviesJ Feely
Jan 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·H SprengerR S McLachlan
Apr 6, 2004·Critical Care Medicine·Richard A Wiklund
Jan 1, 1992·Drug and Alcohol Review·J E Maddison
Oct 25, 2007·Neurochemical Research·R E O'Carroll
Sep 22, 2007·Metabolic Brain Disease·Kevin D MullenMarsha Y Morgan
Feb 1, 1990·Neurochemical Research·J D Rothstein, M Olasmaa
Nov 1, 1992·Journal of Veterinary Internal Medicine·J E Maddison
Mar 1, 1990·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·S H GammalE A Jones
Jun 1, 1990·Postgraduate Medical Journal·L J O'DonnellM J Farthing
Dec 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G Pomier-LayrarguesR F Butterworth
Jan 1, 1995·Acta Anaesthesiologica Scandinavica. Supplementum·G R ParkP Ferenci
Dec 31, 2005·Metabolic Brain Disease·Samir Ahboucha, Roger F Butterworth
Dec 23, 2003·The American Journal of Gastroenterology·Kevin HillDonald J Hillebrand
Dec 8, 1998·Journal of Neuroscience Research·A S Bender, M D Norenberg
Mar 25, 2000·Neurochemistry International·A S Bender, M D Norenberg
May 1, 1997·Clinics in Liver Disease·S Schenker, M K Bay
Mar 1, 1995·The Veterinary Clinics of North America. Small Animal Practice·D Hughes, L G King

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.